NanoTess Inc.
NanoTess Inc is a social enterprise dedicated to providing affordable and accessible nanotechnology innovations for wound care and skin health. Founded by a team with over 40 years of experience in material science, the company focuses on developing cutting-edge, patient-first solutions to improve healing outcomes and reduce healthcare costs. Their flagship product, NanoSALV Catalytic Advanced Wound Care Treatment Matrix, is a Health Canada approved medical device that accelerates wound healing, reduces inflammation, and offers broad-spectrum antimicrobial protection. NanoTess is committed to quality, compassion, resourcefulness, and breaking down barriers to healthcare access.
Industries
Nr. of Employees
small (1-50)
Products
NanoSALV Catalytic Advanced Wound Care Treatment Matrix
A topical amorphous cellulose matrix gel incorporating a composite nanomaterial designed to accelerate wound healing, reduce inflammation, and provide broad-spectrum antimicrobial and anti-biofilm protection while maintaining a moist wound microenvironment.
NanoSALV Catalytic Advanced Wound Care Treatment Matrix
A topical amorphous cellulose matrix gel incorporating a composite nanomaterial designed to accelerate wound healing, reduce inflammation, and provide broad-spectrum antimicrobial and anti-biofilm protection while maintaining a moist wound microenvironment.
Services
Clinical integration and partner success support
Support for healthcare organizations to integrate the topical treatment into care pathways, including access to clinical references, operational resources, and contact-based clinical assistance.
Clinical integration and partner success support
Support for healthcare organizations to integrate the topical treatment into care pathways, including access to clinical references, operational resources, and contact-based clinical assistance.
Expertise Areas
- Wound care and skin health
- Nanomaterials for biomedical applications
- Topical formulation and matrix gels
- Antimicrobial and anti-biofilm technologies
Key Technologies
- Solid-state heterogeneous biocatalysts
- Composite nanomaterials
- Amorphous cellulose matrix gel
- Topical antimicrobial/biofilm protection